SOCS3 promotes TLR4 response in macrophages by feedback inhibiting TGF-β1/Smad3 signaling

Molecular Immunology

Volumn 45, Issue 5, 2008, Pages 1405-1413

  Liu, Xia ^a   Zhang, Yongliang ^b   Yu, Yizhi ^a   Yang, Xiao ^c   Cao, Xuetao ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

Author keywords

Cytokine; Macrophage; SOCS3; TGF 1; TLR4

Indexed keywords

INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SMAD3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; MACROPHAGE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL LINE; FEEDBACK, BIOCHEMICAL; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA1;

EID: 37349112666     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.08.018     Document Type: Article

References (43)

1. Akiyoshi S., Inoue H., Hanai J., Kusanagi K., Nemoto N., Miyazono K., and Kawabata M. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with Smads. J. Biol. Chem. 274 (1999) 35269-35277
2. An H., Xu H., Zhang M., Zhou J., Feng T., Qian C., Qi R., and Cao X. Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism. Blood 105 (2005) 4685-4692
3. An H., Zhao W., Hou J., Zhang Y., Xie Y., Zheng Y., Xu H., Qian C., Zhou J., Yu Y., Liu S., Feng G., and Cao X. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production. Immunity 25 (2006) 919-928
4. Baetz A., Frey M., Heeg K., and Dalpke A.H. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells. J. Biol. Chem. 279 (2004) 54708-54715
5. Berlato C., Cassatella M.A., Kinjyo I., Gatto L., Yoshimura A., and Bazzoni F. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J. Immunol. 168 (2002) 6404-6411
6. Blokzijl A., Dahlqvist C., Reissmann E., Falk A., Moliner A., Lendahl U., and Ibanez C.F. Crosstalk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J. Cell Biol. 163 (2003) 723-728
7. Cacalano N.A., Sanden D., and Johnston J.A. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat. Cell Biol. 3 (2001) 460-465
8. Chen W. Dendritic cells and CD4+CD25+ T regulatory cells, crosstalk between two professionals in immunity versus tolerance. Front. Biosci. 11 (2006) 1360-1370
9. Comalada M., Cardo M., Xaus J., Valledor A.F., Lloberas J., Ventura F., and Celada A. Decorin reverses the repressive effect of autocrine-produced TGF-beta on mouse macrophage activation. J. Immunol. 170 (2003) 4450-4456
10. Dalpke A.H., Opper S., Zimmermann S., and Heeg K. Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs. J. Immunol. 166 (2001) 7082-7089
11. Divanovic S., Trompette A., Atabani S.F., Madan R., Golenbock D.T., Visintin A., Finberg R.W., Tarakhovsky A., Vogel S.N., Belkaid Y., Kurt-Jones E.A., and Karp C.L. Negative regulation of toll-like receptor 4 signaling by the toll-like receptor homolog RP105. Nat. Immunol. 6 (2005) 571-578
12. Fenner J.E., Starr R., Cornish A.L., Zhang J.G., Metcalf D., Schreiber R.D., Sheehan K., Hilton D.J., Alexander W.S., and Hertzog P.J. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat. Immunol. 7 (2006) 33-39
13. Fox S.W., Haque S.J., Lovibond A.C., and Chambers T.J. The possible role of TGF-beta-induced suppressors of cytokine signaling expression in osteoclast/macrophage lineage commitment in vitro. J. Immunol. 170 (2003) 3679-3687
14. Fujimoto M., and Naka T. Regulation of cytokine signaling by SOCS family molecules. Trends Immunol. 24 (2003) 659-666
15. Garcia-Montero A.C., Vasseur S., Giono L.E., Canepa E., Moreno S., Dagorn J.C., and Iovanna J.L. Transforming growth factor beta-1 enhances Smad transcriptional activity through activation of p8 gene expression. Biochem. J. 357 (2001) 249-253
16. Kinjyo I., Inoue H., Hamano S., Fukuyama S., Yoshimura T., Koga K., Takaki H., Himeno K., Takaesu G., Kobayashi T., and Yoshimura A. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1. J. Exp. Med. 203 (2006) 1021-1031
17. Kretzschmar M., Doody J., Timokhina I., and Massague J. A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes 13 (1999) 804-816
18. Kubo M., Hanada T., and Yoshimura A. Suppressors of cytokine signaling and immunity. Nat. Immunol. 4 (2003) 1169-1176
19. Liew F.Y., Xu D., Brint E.K., and O'Neill L.A. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5 (2005) 446-458
20. Liu Y., Dong W., Chen L., Xiang R., Xiao H., De G., Wang Z., and Qi Y. BCL10 mediates lipopolysaccharide/toll-like receptor-4 signaling through interaction with Pellino2. J. Biol. Chem. 279 (2004) 37436-37444
21. Lucas M., Stuart L.M., Savill J., and Lacy-Hulbert A. Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion. J. Immunol. 171 (2003) 2610-2615
22. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6 (2006) 823-835
23. McCartney-Francis N., Jin W., and Wahl S.M. Aberrant toll receptor expression and endotoxin hypersensitivity in mice lacking a functional TGF-beta 1 signaling pathway. J. Immunol. 172 (2004) 3814-3821
24. Moustakas A., and Kardassis D. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 6733-6738
25. Nakao A., Afrakhte M., Moren A., Nakayama T., Christian J.L., Heuchel R., Itoh S., Kawabata M., Heldin N.E., Heldin C.H., and ten Dijke P. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signaling. Nature 389 (1997) 631-635
26. Pardali K., Kurisaki A., Moren A., ten Dijke P., Kardassis D., and Moustakas A. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J. Biol. Chem. 275 (2000) 29244-29256
27. Park S.H., Kim K.E., Hwang H.Y., and Kim T.Y. Regulatory effect of SOCS on NF-kappaB activity in murine monocytes/macrophages. DNA Cell Biol. 22 (2003) 131-139
28. Prele C.M., Keith-Magee A.L., Yerkovich S.T., Murcha M., and Hart P.H. Suppressor of cytokine signaling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-alpha production by human monocytes. Immunology 119 (2006) 8-17
29. Racke M.K., Hu W., and Lovett-Racke A.E. PTX cruiser, driving autoimmunity via TLR4. Trends Immunol. 26 (2005) 289-291
30. Roes J., Choi B.K., and Cazac B.B. Redirection of B cell responsiveness by transforming growth factor beta receptor. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 7241-7246
31. Sato M., Markiewicz M., Yamanaka M., Bielawska A., Mao C., Obeid L.M., Hannun Y.A., and Trojanowska M. Modulation of transforming growth factor-beta (TGF-beta) signaling by endogenous sphingolipid mediators. J. Biol. Chem. 278 (2003) 9276-9282
32. Selvamurugan N., Kwok S., Alliston T., Reiss M., and Partridge N.C. Transforming growth factor-beta 1 regulation of collagenase-3 expression in osteoblastic cells by crosstalk between the Smad and MAPK signaling pathways and their components, Smad2 and Runx2. J. Biol. Chem. 279 (2004) 19327-19334
33. Shinohara H., Inoue A., Toyama-Sorimachi N., Nagai Y., Yasuda T., Suzuki H., Horai R., Iwakura Y., Yamamoto T., Karasuyama H., Miyake K., and Yamanashi Y. Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling. J. Exp. Med. 201 (2005) 333-339
34. Stoiber D., Kovarik P., Cohney S., Johnston J.A., Steinlein P., and Decker T. Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-gamma. J. Immunol. 163 (1999) 2640-2647
35. Stroschein S.L., Wang W., and Luo K. Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor beta-induced Smad-dependent transcriptional activation. J. Biol. Chem. 274 (1999) 9431-9441
36. Takagi H., Sanada T., Minoda Y., and Yoshimura A. Regulation of cytokine and toll-like receptor signaling by SOCS family genes. Nippon Rinsho 62 (2004) 2189-2196
37. Takeda K., Clausen B.E., Kaisho T., Tsujimura T., Terada N., Forster I., and Akira S. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of STAT3 in macrophages and neutrophils. Immunity 10 (1999) 39-49
38. Williams L.K., Ownby D.R., Maliarik M.J., and Johnson C.C. The role of endotoxin and its receptors in allergic disease. Ann. Allergy Asthma Immunol. 94 (2005) 323-332
39. Xu W., Angelis K., Danielpour D., Haddad M.M., Bischof O., Campisi J., Stavnezer E., and Medrano E.E. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 5924-5929
40. Xu H., An H., Yu Y., Zhang M., Qi R., and Cao X. Ras participates in CpG oligodeoxynucleotide signaling through association with toll-like receptor 9 and promotion of interleukin-1 receptor-associated kinase/tumor necrosis factor receptor-associated factor 6 complex formation in macrophages. J. Biol. Chem. 278 (2003) 36334-36340
41. Yakymovych I., Ten Dijke P., Heldin C.H., and Souchelnytskyi S. Regulation of Smad signaling by protein kinase C. FASEB J. 15 (2001) 553-555
42. Yang X., Letterio J.J., Lechleider R.J., Chen L., Hayman R., Gu H., Roberts A.B., and Deng C. Targeted disruption of Smad3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J. 18 (1999) 1280-1291
43. Yasukawa H., Ohishi M., Mori H., Murakami M., Chinen T., Aki D., Hanada T., Takeda K., Akira S., Hoshijima M., Hirano T., Chien K.R., and Yoshimura A. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 4 (2003) 551-556